ILMN is short-term to mid-term bearish, long term- bullish. Relief bounce is overdue as the selling pressure seems to be overheating and could soon be exhausted.
ILMN is still a leader in gene sequencing with roughly 70% market share, but its short-term prospect is damaged by waning consumer interest and tariff.
Looking for daily close above 275 and weekly close above 300.
Potential short play once the price reverses up to the supply zone.
ILMN is still a leader in gene sequencing with roughly 70% market share, but its short-term prospect is damaged by waning consumer interest and tariff.
Looking for daily close above 275 and weekly close above 300.
Potential short play once the price reverses up to the supply zone.
